CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Ionis Pharmaceuticals (IONS) Stock Looks Pricey On Its 45% YTD Slide

Negative
AI Analysis

Summary

Ionis Pharmaceuticals stock has declined 45% year-to-date and is viewed as overvalued at current levels, according to an analyst commentary.

Importance:2/10
Sentiment:
-0.60
stock_performancevaluationprice_decline
Related Companies

Read the original article

Published by yahoo_finance on September 25, 2026 12:18 AM

Read Original